Thrombotic Microangiopathies

Abstract Number: PB1882

Acquired Thrombotic Thrombocytopenic Purpura: Key Findings of Patients from Southern Italy

G.L. Tiscia¹, F. Cappucci¹, L. Fischetti¹, C. Battista², A. Ostuni², G. Giordano³, G. Tarantini⁴, T.M. Santeramo⁴, G. Giuffrida⁵, D. Nicolosi⁵, P.R. Scalzulli⁶, N. Cascavilla⁶, L. di Mauro⁷, E. Grandone¹

Abstract Number: OC 07.2

ADAMTS13 Conformation Is Closed in Acquired Thrombotic Thrombocytopenic Purpura in the Absence of Anti-ADAMTS13 Autoantibodies

E. Roose¹, B.S. Joly^2,3, A.-S. Schelpe¹, I. Pareyn¹, A. Vandenbulcke¹, C. Tersteeg¹, S.F. De Meyer¹, P. Coppo⁴, A. Veyradier^2,3, K. Vanhoorelbeke¹

Abstract Number: PB1947

An Unusual Case of Cerebral Cavernous Malformation Complicated with Consumptive Coagulopathy and Heightened Fibrinolysis

M.-C. Shen¹, C.-Y. Lin¹, W.-L. Chen², Y.-H. Shih¹, Y.-C. Huang³

Abstract Number: PB1919

Anti-β2-Glycoprotein I and Anti-Prothrombin Antibodies Cause Lupus Anticoagulant by Interfering with Factor Xa-Mediated Factor V Activation

T. Noordermeer¹, J.E. Molhoek², S.A.E. Sebastian², S. Drost-Verhoef², A.C.W. van Wesel², P.G. de Groot³, J.C.M. Meijers^4,5, R.T. Urbanus¹

Abstract Number: PB1911

Antiphospholipid Antibodies “Multi-Positivity” in Women with Thromboembolism

J. Khizroeva, V. Bitsadze, N. Makatsariya, M. Arslanbekova, K. Sultangadzhieva, A. Vorobev, I. Khamani, N. Babaeva, A. Antonova

Abstract Number: PB1904

Assessment and Comparison of Acquired Activated Protein C Resistance with Two Thrombin Generation Methods, CAT and ST-Genesia, in APS and SLE Patients

P.J. Lane¹, I. Mackie¹, D. Isenberg^2,3, H. Cohen^1,4, M. Efthymiou¹

Abstract Number: PB1885

Association of Plasmic Score with Neurological Symptoms in Patients with Thrombotic Thrombocytopenic Purpura (TTP)

J.T.d.S. Castro¹, B.D.M. Mazetto², A.P. Rosa², G. Yamagutti³, M. Colella³, E.V. Paulo³, J.A. Bizachi³, F. Reis¹, F.A. Orsi³

Abstract Number: PB1862

Automated Chemiluminescent ADAMTS13 Activity Immunoassay for Thrombotic Thrombocytopenic Purpura Diagnosis and Follow-up

N. Beranger^1,2, S. Benghezal^1,2, B. Joly^1,2, S. Capdenat^1,2, A. Delton^1,2, A. Stepanian^1,2, P. Coppo³, A. Veyradier^1,2

Abstract Number: PB1863

Caplacizumab in a Case of Acquired Thrombotic Thrombcytopenic Purpura (TTP) Poor Responsive to Plasma Exchange and Immunosuppressive Therapy

A. Molteni, C. Dellanoce, A. Pasini, O. Paoletti, A. Mancini, V. Cancelli, M. Tajana, M. Tala, S. Belletti, R. Morandini, C. Fiamenghi, P. Spedini, S. Testa

Abstract Number: PB1923

Catastrophic Antiphospholipid Syndrome, Kikuchi-Fujimoto Disease and Adult-Onset Still Disease: An Unusual Association

S.D.A. Peres¹, G. Remondino², F. Aranda¹, A. Lucero¹, G. Lencinas¹, E. Cunto¹, G.F. de Larrañaga¹

Abstract Number: PB1932

CliA Immunoassay: Better Identification of High Thrombotic Risk Triple Positive Antiphospholipid Patients

B. Montaruli¹, A. Romito¹, C. Guiotto¹, T. Bertero², P. Sivera³, D. Cosseddu¹

Abstract Number: PB1867

Clinical Analysis of 83 Patients with Thrombotic Thrombocytopenic Purpura

W. Xiyan, L. Xiaofan, X. Feng, L. Wei, C. Yunfei, H. Yueting, F. Rongfeng, Z. Lei, Y. Renchi

Abstract Number: PB1889

Clinical and Economic Impacts of a New Rapid ADAMTS-13 Assay for the Diagnosis of Suspected Thrombotic Thrombocytopenic Purpura

C. Novelli¹, B. Montaruli², L. Solfietti³, A. Valpreda⁴, M. Bazzan³, B. Basolo³, I.L.A. Beverina¹, M. Milan⁵, B. Brando¹

Abstract Number: PB1909

Cohort of Patients with Triple Antiphospholipid Antibodies: Differences between Asymptomatic and Symptomatic Individuals

P. Casais^1,2, J. Salviú², S. Meschengieser²

Abstract Number: PB1945

Complement Pathway and Endothelial Dysfunction in Severe Preeclampsia

M. Palomo¹, M. Blasco², F. Crispi³, S. Torramade-Moix⁴, P. Molina⁴, J.M. Campistol², J.C. Garcia Pagan⁵, E. Gratacos³, G. Escolar⁴, M. Diaz-Ricart⁴

Abstract Number: PB1925

Complement Regulatory Abnormalities are Frequent in Patients with Catastrophic APS and Refractory Patients Respond Rapidly to Eculizumab Treatment

H. Liebman¹, I. Weitz²

Abstract Number: PB1933

Contribution of Beta2 Glycoprotein1 IgA (B2GP1 IgA) Antibodies Research in Diagnosis of Seronegative Antiphospholipid Syndrome in Cerebral Thrombosis: A Case Series of 21 Patients

I. Hocine, Y. Ferhat-Hamida, G. Hariti

Abstract Number: PB1884

Correlation between Phenotype-genotype versus in-silico Prediction of Novel and Known Disease-causing Variants in Upshaw-Schulman Syndrome Patients in a Single Institution of Argentina

J. Paiva¹, A.I. Woods², A. Kinen¹, M.M. Casinelli¹, A. Sanchez-Luceros^1,2

Abstract Number: PB/CO21

COVID-19 Pandemic: Dissecting Coagulation apart from Inflammation

J. Gonzalez-Lugo¹, S. Rahman¹, M. Barouqa², J. Szymanski², H. Billett¹, M. Reyes Gil²

Abstract Number: PB1864

Current Possibilities of ADAMTS 13 Diagnostics – Advantages and Limitations

P. Bradacova¹, L. Slavik², J. Ulehlova², J. Prochazkova², A. Hlusi², K. Chasakova³